Peter M. van Koetsveld
About
Peter M. van Koetsveld is a scholar working on Endocrinology, Diabetes and Metabolism, Epidemiology and Oncology.
According to data from OpenAlex, Peter M. van Koetsveld has authored 72 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Endocrinology, Diabetes and Metabolism, 31 papers in Epidemiology and 22 papers in Oncology. Recurrent topics in Peter M. van Koetsveld's work include Neuroendocrine Tumor Research Advances (30 papers), Pituitary Gland Disorders and Treatments (29 papers) and Growth Hormone and Insulin-like Growth Factors (17 papers). Peter M. van Koetsveld is often cited by papers focused on Neuroendocrine Tumor Research Advances (30 papers), Pituitary Gland Disorders and Treatments (29 papers) and Growth Hormone and Insulin-like Growth Factors (17 papers). Peter M. van Koetsveld collaborates with scholars based in Netherlands, Italy and United States. Peter M. van Koetsveld's co-authors include Leo J. Hofland, Steven W. J. Lamberts, Wouter W. de Herder, Richard A. Feelders, Marlijn Waaijers, Aart‐Jan van der Lely, P. Martin van Hagen, Diana Sprij-Mooij, Joost van der Hoek and Fadime Dogan and has published in prestigious journals such as PLoS ONE, The Journal of Clinical Endocrinology & Metabolism and Cancer Research.
In The Last Decade
Peter M. van Koetsveld
70 papers receiving 2.5k citations
Peers
Peter M. van Koetsveld
Béatrice Parfait France
Luis V. Syro Colombia
Erika Peverelli Italy
Péter Igaz Hungary
Giuseppe Costante Italy
Masahiko Tosaka Japan
Christoforos Giatzakis United States
Knut Dietzmann Germany
Agnès Ribeiro France
Hui Sun China
Citations per year, relative to Peter M. van Koetsveld Peter M. van Koetsveld (= 1×)
peers
Béatrice Parfait
Countries citing papers authored by Peter M. van Koetsveld
Since
Specialization
Citations
This map shows the geographic impact of Peter M. van Koetsveld's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter M. van Koetsveld with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter M. van Koetsveld more than expected).
Fields of papers citing papers by Peter M. van Koetsveld
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Peter M. van Koetsveld. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter M. van Koetsveld. The network helps show where Peter M. van Koetsveld may publish in the future.
Co-authorship network of co-authors of Peter M. van Koetsveld
This figure shows the co-authorship network connecting the top 25 collaborators of Peter M. van Koetsveld. A scholar is included among the top collaborators of Peter M. van Koetsveld based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter M. van Koetsveld. Peter M. van Koetsveld is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Pas, Rob van der, Peter M. van Koetsveld, Fadime Dogan, et al.. (2025). A Prospective Trial With Ketoconazole Induction Therapy and Octreotide Maintenance Treatment for Cushing's Disease. Journal of the Endocrine Society. 9(7). bvaf089–bvaf089.
2.
Feelders, Richard A., Fadime Dogan, Peter M. van Koetsveld, et al.. (2023). The Role of the IGF2 Methylation Score in Diagnosing Adrenocortical Tumors with Unclear Malignant Potential—Feasibility of Formalin-Fixed Paraffin-Embedded Tissue. Biomedicines. 11(7). 2013–2013.
3.
Koetsveld, Peter M. van, et al.. (2022). The Class I HDAC Inhibitor Valproic Acid Strongly Potentiates Gemcitabine Efficacy in Pancreatic Cancer by Immune System Activation. Biomedicines. 10(3). 517–517.
4.
Gatto, Federico, Richard A. Feelders, Peter M. van Koetsveld, et al.. (2022). Dissecting the In Vitro Efficacy of Octreotide and Cabergoline in GH- and GH/PRL-Secreting Pituitary Tumors. The Journal of Clinical Endocrinology & Metabolism. 108(5). e98–e109.
5.
Berk, Şeyda, J. A. M. J. L. Janssen, Peter M. van Koetsveld, et al.. (2021). Modifying Effects of Glucose and Insulin/Insulin-Like Growth Factors on Colon Cancer Cells. Frontiers in Oncology. 11. 645732–645732.
6.
Martino, Maria Cristina De, Peter M. van Koetsveld, Richard A. Feelders, et al.. (2019). IGF and mTOR pathway expression and in vitro effects of linsitinib and mTOR inhibitors in adrenocortical cancer. Endocrine. 64(3). 673–684.
7.
Herrera‐Martínez, Aura D., Richard A. Feelders, Peter M. van Koetsveld, et al.. (2019). Effect of the Tryptophan Hydroxylase Inhibitor Telotristat on Growth and Serotonin Secretion in 2D and 3D Cultured Pancreatic Neuroendocrine Tumor Cells. Neuroendocrinology. 110(5). 351–363.
8.
Vandamme, Timon, Matthias Beyens, Ken Op de Beeck, et al.. (2016). Long-term acquired everolimus resistance in pancreatic neuroendocrine tumours can be overcome with novel PI3K-AKT-mTOR inhibitors. British Journal of Cancer. 114(6). 650–658.
9.
Koetsveld, Peter M. van, Giovanni Vitale, Richard A. Feelders, et al.. (2013). Interferon-β is a potent inhibitor of cell growth and cortisol production in vitro and sensitizes human adrenocortical carcinoma cells to mitotane. Endocrine Related Cancer. 20(3). 443–454.
10.
Hofland, Johannes, Wouter W. de Herder, Leo J. Hofland, et al.. (2012). Regulation of steroidogenesis in a primary pigmented nodular adrenocortical disease-associated adenoma leading to virilization and subclinical Cushing's syndrome. European Journal of Endocrinology. 168(1). 67–74.
11.
Hofland, Johannes, Patric J. D. Delhanty, Jacobie Steenbergen, et al.. (2012). Melanocortin 2 Receptor-Associated Protein (MRAP) and MRAP2 in Human Adrenocortical Tissues: Regulation of Expression and Association with ACTH Responsiveness. The Journal of Clinical Endocrinology & Metabolism. 97(5). E747–E754.
12.
Erdmann, Joris I., Giovanni Vitale, Peter M. van Koetsveld, et al.. (2011). Effects of Interferons α/β on the Proliferation of Human Micro- and Macrovascular Endothelial Cells. Journal of Interferon & Cytokine Research. 31(5). 451–458.
13.
Florio, Tullio, Federica Barbieri, Renato Spaziante, et al.. (2008). Efficacy of a dopamine-somatostatin chimeric molecule, BIM-23A760, in the control of cell growth from primary cultures of human non-functioning pituitary adenomas: a multi-center study. Endocrine Related Cancer. 15(2). 583–596.
14.
Vitale, Giovanni, Michele Caraglia, Peter M. van Koetsveld, et al.. (2008). Potential role of type I interferons in the treatment of pituitary adenomas. Reviews in Endocrine and Metabolic Disorders. 10(2). 125–133.
15.
Bhatti, S.F.M., Leo J. Hofland, Peter M. van Koetsveld, et al.. (2006). Effects of food intake and food withholding on plasma ghrelin concentrations in healthy dogs. American Journal of Veterinary Research. 67(9). 1557–1563.
16.
Hoek, Joost van der, Marlijn Waaijers, Peter M. van Koetsveld, et al.. (2005). Distinct functional properties of native somatostatin receptor subtype 5 compared with subtype 2 in the regulation of ACTH release by corticotroph tumor cells. American Journal of Physiology-Endocrinology and Metabolism. 289(2). E278–E287.
17.
Hofland, Leo J., Joost van der Hoek, Peter M. van Koetsveld, et al.. (2004). The Novel Somatostatin Analog SOM230 Is a Potent Inhibitor of Hormone Release by Growth Hormone- and Prolactin-Secreting Pituitary Adenomasin Vitro. The Journal of Clinical Endocrinology & Metabolism. 89(4). 1577–1585.
18.
Feelders, Richard A., Steven W. J. Lamberts, Leo J. Hofland, et al.. (2003). Luteinizing Hormone (LH)-Responsive Cushing’s Syndrome: The Demonstration of LH Receptor Messenger Ribonucleic Acid in Hyperplastic Adrenal Cells, which Respond to Chorionic Gonadotropin and Serotonin Agonistsin Vitro. The Journal of Clinical Endocrinology & Metabolism. 88(1). 230–237.
19.
Hofland, Leo J., Peter M. van Koetsveld, & Steven W. J. Lamberts. (1990). Percoll density gradient centrifugation of rat pituitary tumor cells: a study of functional heterogeneity within and between tumors with respect to growth rates, prolactin production and responsiveness to the somatostatin analog SMS 201–995. European Journal of Cancer and Clinical Oncology. 26(1). 37–44.
20.
Hofland, Leo J., Peter M. van Koetsveld, T. Verleun, & Steven W. J. Lamberts. (1990). Long-term culture of rat mammotrope and somatotrope subpopulations separated on continuous Percoll density gradients: Effects of dopamine, TRH, GHRH and somatostatin. European Journal of Endocrinology. 122(1). 127–136.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Béatrice Parfait Breakdown of academic impact, for papers by Luis V. Syro Breakdown of academic impact, for papers by Erika Peverelli Breakdown of academic impact, for papers by Péter Igaz Breakdown of academic impact, for papers by Giuseppe Costante Breakdown of academic impact, for papers by Masahiko Tosaka Breakdown of academic impact, for papers by Christoforos Giatzakis Breakdown of academic impact, for papers by Knut Dietzmann Breakdown of academic impact, for papers by Agnès Ribeiro Breakdown of academic impact, for papers by Hui Sun